NLRP3 and hepatocellular carcinoma: Additionally, NLRP3-upregulated 17β-estradiol (E2) significantly inhibited the malignant biological behavior of HCC cells through the E2/ERβ/MAPK pathway, further demonstrating the protective effect of NLRP3 in HCC [45].